NeuroSense Therapeutics Ltd. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NRSNW and buy or sell other stocks, ETFs, and their options commission-free!

About NRSNW

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). 

CEO
Alon Ben-Noon, MBA
CEOAlon Ben-Noon, MBA
Employees
—
Employees—
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
—
Employees—

NRSNW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
1.38K
Average volume1.38K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.00
52 Week high$1.00
52 Week low
$0.1531
52 Week low$0.1531

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.